Published in AIDS Weekly, January 6th, 2003
"The HIV-Tat protein can be released extracellularly where it is able to recruit leukocytes and induce angiogenesis," explained Roberto Benelli and colleagues at National Institute for Cancer Research in Genoa.
Angiostatin blocks the inflammatory angiogenic response to extracellular Tat, Benelli and coauthors found.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.